Literature DB >> 21776331

Conceptual aspects of self and nonself discrimination.

Segundo Gonzalez1, Ana Pilar González-Rodríguez, Beatriz Suárez-Álvarez, Alejandro López-Soto, Leticia Huergo-Zapico, Carlos Lopez-Larrea.   

Abstract

Due to the variety and complexity of microorganisms, the mechanisms needed for pathogen recognition are diverse. Innate immune recognition is mainly based on a series of germ-line encoded receptors that have been selected by evolution to recognize nonself molecules present in microorganisms. Innate immunity also recognizes changes in our cells caused by infection, such as the lack or induction of self molecules. Adaptative immunity somatically generates large repertories of receptors which collectively recognize any nonself antigen. These receptors are randomly generated, and the adaptative immune system has to learn how to eliminate or inactivate cells with high avidity receptors for self molecules. Given the enormous variety of microbe structures and immune receptors, the difference between self and nonself is not absolute; it depends on the threshold of activation. In genetically diverse populations, individuals who have this activation threshold too far from the average may suffer an autoimmune reaction. Accumulation of mutations in cancer cells generates neoantigens that may be also recognized as nonself molecules, but the extent of self and nonself discrimination limits immune responsiveness to them. Surprisingly, most of the molecules expressed by cancer cells recognized by the immune system are non mutated self molecules.

Entities:  

Year:  2011        PMID: 21776331      PMCID: PMC3136900          DOI: 10.4161/self.2.1.15094

Source DB:  PubMed          Journal:  Self Nonself        ISSN: 1938-2030


  37 in total

Review 1.  Ligands for natural killer cell receptors: redundancy or specificity.

Authors:  A Cerwenka; L L Lanier
Journal:  Immunol Rev       Date:  2001-06       Impact factor: 12.988

Review 2.  The immune system evolved to discriminate infectious nonself from noninfectious self.

Authors:  C A Janeway
Journal:  Immunol Today       Date:  1992-01

3.  How did our complex immune system evolve?

Authors:  Max D Cooper; Brantley R Herrin
Journal:  Nat Rev Immunol       Date:  2010-01       Impact factor: 53.106

Review 4.  Antigen presentation in the thymus for positive selection and central tolerance induction.

Authors:  Ludger Klein; Maria Hinterberger; Gerald Wirnsberger; Bruno Kyewski
Journal:  Nat Rev Immunol       Date:  2009-12       Impact factor: 53.106

Review 5.  Cancer immunoediting: from immunosurveillance to tumor escape.

Authors:  Gavin P Dunn; Allen T Bruce; Hiroaki Ikeda; Lloyd J Old; Robert D Schreiber
Journal:  Nat Immunol       Date:  2002-11       Impact factor: 25.606

Review 6.  Mechanisms of the self/non-self-survey in the defense against cancer: potential for chemoprevention?

Authors:  Ricky A Sharma; Michael J Browning
Journal:  Crit Rev Oncol Hematol       Date:  2005-10       Impact factor: 6.312

Review 7.  Sterile inflammation: sensing and reacting to damage.

Authors:  Grace Y Chen; Gabriel Nuñez
Journal:  Nat Rev Immunol       Date:  2010-11-19       Impact factor: 53.106

8.  Vitiligo in patients with melanoma: normal tissue antigens can be targets for cancer immunotherapy.

Authors:  S A Rosenberg; D E White
Journal:  J Immunother Emphasis Tumor Immunol       Date:  1996-01

Review 9.  Immune-mediated dormancy: an equilibrium with cancer.

Authors:  Michele W L Teng; Jeremy B Swann; Catherine M Koebel; Robert D Schreiber; Mark J Smyth
Journal:  J Leukoc Biol       Date:  2008-05-30       Impact factor: 4.962

10.  Decreased tumor surveillance in perforin-deficient mice.

Authors:  M E van den Broek; D Kägi; F Ossendorp; R Toes; S Vamvakas; W K Lutz; C J Melief; R M Zinkernagel; H Hengartner
Journal:  J Exp Med       Date:  1996-11-01       Impact factor: 14.307

View more
  2 in total

Review 1.  Bioactive Nanoparticles for Cancer Immunotherapy.

Authors:  Suchithra Poilil Surendran; Myeong Ju Moon; Rayoung Park; Yong Yeon Jeong
Journal:  Int J Mol Sci       Date:  2018-12-04       Impact factor: 5.923

2.  Small cell lung cancer stem cells display mesenchymal properties and exploit immune checkpoint pathways in activated cytotoxic T lymphocytes.

Authors:  M Alper Kursunel; Ekim Z Taskiran; Ece Tavukcuoglu; Hamdullah Yanik; Funda Demirag; Beren Karaosmanoglu; Feyza Gul Ozbay; Aysegul Uner; Dorina Esendagli; Derya Kizilgoz; Ulku Yilmaz; Gunes Esendagli
Journal:  Cancer Immunol Immunother       Date:  2021-07-06       Impact factor: 6.968

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.